![\"\"](\"http://i.turner.ncaa.com/dr/ncaa/ncaa/release/sites/default/files/images/2011/Something_To_Talk_About.jpg\")
![\"\"](\"http://i.turner.ncaa.com/dr/ncaa/ncaa/release/sites/default/files/images/Goulakos-colgate-mhock-013113.JPG\")
Sophomore defenseman Spiro Goulakos has left Colgate for treatment of Hodgkin’s lymphoma.
Colgate Athletics
• After contributing two assists against No. 7 Yale for his sixth multiple performance of the season on Saturday, sophomore defenseman Spiro Goulakos has left school for treatment of Hodgkin’s lymphoma, a type of cancer originating from white blood cells in the lymph nodes. He will undergo chemotherapy in his hometown of Montreal.
This post was imported from a legacy archive. Please excuse any formatting inconsistencies.